Data as of May 20
| -0.03 / -0.42%|
The 4 analysts offering 12-month price forecasts for Durata Therapeutics Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 14.00. The median estimate represents a +110.67% increase from the last price of 7.12.
The current consensus among 4 polled investment analysts is to Buy stock in Durata Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.